AMGEN INC — Director's Dealing 2012

Nov 26, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-11-26

Reporting Person: OMENN GILBERT S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-26	Common Stock	M	16000	$50.78	Acquired	192783	Direct
2012-11-26	Common Stock	M	5000	$74.89	Acquired	197783	Direct
2012-11-26	Common Stock	M	5000	$62.55	Acquired	202783	Direct
2012-11-26	Common Stock	S	26000	$87.1148	Disposed	176783	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-26	Nqso (Right to Buy)	$50.78	M	16000	Disposed	2013-01-27	Common Stock (16000)	Direct
2012-11-26	Nqso (Right to Buy)	$74.89	M	5000	Disposed	2013-03-15	Common Stock (5000)	Direct
2012-11-26	Nqso (Right to Buy)	$62.55	M	5000	Disposed	2014-04-26	Common Stock (5000)	Direct

Footnotes

F1: The price reported is an average price. The prices ranged from $87.095 to $87.13 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F2: These shares include 108 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.